Janus Kinase 3–Activating Mutations Identified in Natural Killer/T-cell Lymphoma

Abstract

Gene mutations causing NKTCL have not been fully identified. Through exome sequencing, we identified activating mutations of JAK3 that may play a significant role in the pathogenesis of NKTCLs. Our findings have important implications for the management of patients with NKTCLs.